Robert Roebling

941 total citations
16 papers, 422 citations indexed

About

Robert Roebling is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert Roebling has authored 16 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert Roebling's work include Epilepsy research and treatment (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Robert Roebling is often cited by papers focused on Epilepsy research and treatment (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Robert Roebling collaborates with scholars based in Germany, United States and Belgium. Robert Roebling's co-authors include Holger Lerche, Michaela Fritz, Holger Barth, Klaus Aktories, Oliver Gruber, Ingo Uttner, Eduard Kraft, Björn Steiniger‐Brach, Michael Wolf and Angela Rosenbohm and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

In The Last Decade

Robert Roebling

16 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Roebling Germany 10 182 165 122 120 108 16 422
Steffen Leiz Germany 11 226 1.2× 133 0.8× 148 1.2× 111 0.9× 142 1.3× 24 586
Hisashi Kawawaki Japan 12 177 1.0× 96 0.6× 101 0.8× 173 1.4× 78 0.7× 63 541
B. Dalla Bernardina Italy 11 354 1.9× 158 1.0× 105 0.9× 126 1.1× 135 1.3× 16 509
Özlem Çokar Türkiye 11 281 1.5× 160 1.0× 44 0.4× 86 0.7× 117 1.1× 45 500
Jiro Shimomura Japan 6 198 1.1× 152 0.9× 106 0.9× 158 1.3× 47 0.4× 9 379
Noriyuki Akasaka Japan 14 214 1.2× 122 0.7× 76 0.6× 175 1.5× 122 1.1× 27 566
Tommy Stödberg Sweden 14 174 1.0× 67 0.4× 79 0.6× 169 1.4× 69 0.6× 22 625
Stefan Kuczaty Germany 8 407 2.2× 164 1.0× 107 0.9× 82 0.7× 221 2.0× 11 570
Miriam Kessi China 11 158 0.9× 117 0.7× 62 0.5× 160 1.3× 50 0.5× 34 440

Countries citing papers authored by Robert Roebling

Since Specialization
Citations

This map shows the geographic impact of Robert Roebling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Roebling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Roebling more than expected).

Fields of papers citing papers by Robert Roebling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Roebling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Roebling. The network helps show where Robert Roebling may publish in the future.

Co-authorship network of co-authors of Robert Roebling

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Roebling. A scholar is included among the top collaborators of Robert Roebling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Roebling. Robert Roebling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vossler, David G., И. Е. Повереннова, Masako Watanabe, et al.. (2024). Long‐term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic–clonic seizures: An open‐label extension trial. Epilepsia. 65(12). 3488–3500. 1 indexed citations
2.
Utidjian, Levon, Nicholas S. Abend, Robert Roebling, et al.. (2024). Retrospective Multicenter Cohort Study on Safety and Electroencephalographic Response to Lacosamide for Neonatal Seizures. Pediatric Neurology. 155. 18–25. 2 indexed citations
3.
4.
Utidjian, Levon, Nicholas S. Abend, Mark S. Wainwright, et al.. (2023). Safety of intravenous lacosamide in hospitalized children and neonates. Epilepsia. 64(9). 2297–2309. 7 indexed citations
5.
6.
Ben‐Menachem, Elinor, et al.. (2021). Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial. Epilepsia Open. 6(3). 618–623. 13 indexed citations
7.
Vossler, David G., Susanne Knake, Terence J. O’Brien, et al.. (2020). Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial. Journal of Neurology Neurosurgery & Psychiatry. 91(10). 1067–1075. 58 indexed citations
8.
Mintzer, Scott, Svetlana Dimova, Ying Zhang, et al.. (2020). Effects of lacosamide and carbamazepine on lipids in a randomized trial. Epilepsia. 61(12). 2696–2704. 16 indexed citations
9.
Lim, Jessica, Li Wang, Nicky Best, et al.. (2019). Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of Bias. Therapeutic Innovation & Regulatory Science. 54(4). 850–860. 13 indexed citations
10.
Schaffler, K., Laurent B. Nicolas, Andreas Borta, et al.. (2017). Investigation of the predictive validity of laser‐EPs in normal, UVB‐inflamed and capsaicin‐irritated skin with four analgesic compounds in healthy volunteers. British Journal of Clinical Pharmacology. 83(7). 1424–1435. 13 indexed citations
11.
Holzer, Franz Josef, Andrea O. Rossetti, Dominik Zumsteg, et al.. (2012). Antibody-Mediated Status Epilepticus: A Retrospective Multicenter Survey. European Neurology. 68(5). 310–317. 36 indexed citations
12.
Groen, Georg, et al.. (2011). Increased Resting-State Perfusion after Repeated Encoding Is Related to Later Retrieval of Declarative Associative Memories. PLoS ONE. 6(5). e19985–e19985. 19 indexed citations
13.
Weber, Yvonne, Robert Roebling, Jan Kassubek, et al.. (2010). Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology. 74(14). 1108–1117. 99 indexed citations
14.
Roebling, Robert, Klaus Huch, Jan Kassubek, Holger Lerche, & Yvonne Weber. (2009). Cervical spinal MRI in a patient with a vagus nerve stimulator (VNS). Epilepsy Research. 84(2-3). 273–275. 4 indexed citations
15.
Roebling, Robert, et al.. (2009). Evaluation of cognition, structural, and functional MRI in juvenile myoclonic epilepsy. Epilepsia. 50(11). 2456–2465. 77 indexed citations
16.
Barth, Holger, Robert Roebling, Michaela Fritz, & Klaus Aktories. (2002). The Binary Clostridium botulinum C2 Toxin as a Protein Delivery System. Journal of Biological Chemistry. 277(7). 5074–5081. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steffen Leiz Breakdown of academic impact, for papers by Hisashi Kawawaki Breakdown of academic impact, for papers by B. Dalla Bernardina Breakdown of academic impact, for papers by Özlem Çokar Breakdown of academic impact, for papers by Jiro Shimomura Breakdown of academic impact, for papers by Noriyuki Akasaka Breakdown of academic impact, for papers by Tommy Stödberg Breakdown of academic impact, for papers by Stefan Kuczaty Breakdown of academic impact, for papers by Miriam Kessi
Rankless by CCL
2026